McKesson, Bindley Cautious On Rx Imports; Larger Opportunity Is Medicare
Executive Summary
McKesson will wait for implementing regulations covering prescription drug importation before determining the business opportunity from the new import law, the company told investors during an Oct. 24 conference call.